Clinical neurogenetics: autism spectrum disorders

Area of Science:

• Neurodevelopmental disorders
• Genetics
• Pediatric neurology

Background:

• Autism spectrum disorder (ASD) is defined by challenges in social interaction, communication, and restricted interests.
• Both genetic alterations (de novo or inherited) and non-genetic factors like prenatal infections are implicated in ASD etiology.
• Rapid early brain growth in infancy is a potential underlying factor for ASD deficits in many individuals.

Purpose of the Study:

• To summarize the current understanding of autism spectrum disorder.
• To highlight the etiological factors contributing to ASD.
• To review current and potential future treatment strategies for ASD.

Main Methods:

• Review of existing literature on autism spectrum disorder.
• Analysis of evidence from genetic studies.
• Examination of findings from neuroimaging (MRI) and autopsy studies.
• Evaluation of clinical trial data for behavioral and pharmacological interventions.

Main Results:

• Strong evidence supports the role of genetic alterations in ASD causation.
• Non-genetic factors, such as in utero infections, may also contribute to ASD.
• Studies indicate a correlation between rapid infant brain size increase and ASD deficits in a significant subset of patients.
• Behavioral and pharmacological treatments demonstrate clinical benefits for individuals with ASD.

Conclusions:

• ASD is a complex neurodevelopmental disorder with multifactorial causes.
• Early brain development, influenced by genetics and environment, is critical in ASD.
• Current treatments offer benefits, and future genotype-specific therapies hold potential for improved outcomes.